Showing results (391-400 of 456) with videos related to
Sort By:
Pageof 46
Frontiers in Bioscience (Landmark Edition)|October 5, 2023
SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2Fei-Fei Luo, Jing Wang, Zhan-Fei Zhang, et al.Journal of Medicinal Chemistry|May 29, 2025
Structural Optimization of Next-Generation TRK Inhibitors against Acquired Drug Resistance Mutations for the Treatment of Solid TumorsZichao Xu, Yueling Liu, Peng Wang, et al.Oncology Reports|August 15, 2018
Inhibitor of apoptosis protein‑like protein‑2: A novel growth accelerator for breast cancer cellsLin Zhu, Weihua Zhou, Xidi Zhu, et al.International Journal of Oncology|January 20, 2016
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthomaAkiko Kanzaki, Mitsuhiro Kudo, Shin-Ichi Ansai, et al.Theranostics|September 28, 2022
18F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axisYuchen Jiang, Qinghe Zeng, Qinghui Jiang, et al.European Journal of Medicinal Chemistry|December 21, 2018
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinomaQi Wang, Yang Dai, Yinchun Ji, et al.Acta Pharmaceutica Sinica. B|March 29, 2021
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitorsXiaowei Wu, Mengdi Dai, Rongrong Cui, et al.Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsXia Peng, Pengcong Hou, Yi Chen, et al.Journal of Medicinal Chemistry|November 11, 2022
Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL InhibitorsShingpan Chan, Yunong Zhang, Jie Wang, et al.Acta Pharmacologica Sinica|April 5, 2016
Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitorsTong-Chao Liu, Xia Peng, Yu-Chi Ma, et al.Pageof 46